Alexandra Pichl Selected Research

Nitric Oxide (Nitrogen Monoxide)

1/2020	NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD.
1/2019	Riociguat for treatment of pulmonary hypertension in COPD: a translational study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexandra Pichl Research Topics

Disease

7	Emphysema 01/2021 - 10/2011
6	Pulmonary Hypertension 01/2021 - 10/2011
5	Chronic Obstructive Pulmonary Disease (COPD) 07/2020 - 11/2013
2	Vascular Remodeling 04/2014 - 10/2011
1	Inflammation (Inflammations) 01/2018
1	Right Ventricular Hypertrophy 01/2015
1	Hypoxia (Hypoxemia) 04/2014
1	Pulmonary Emphysema 11/2013

Drug/Important Bio-Agent (IBA)

8	SmokeIBA 01/2021 - 10/2011
2	NADPH Oxidases (NAD(P)H oxidase)IBA 07/2020 - 01/2020
2	Superoxides (Superoxide)IBA 01/2020 - 11/2013
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 01/2019
2	Soluble Guanylyl CyclaseIBA 01/2015 - 06/2014
1	Pancreatic Elastase (Elastase)IBA 01/2021
1	Peroxynitrous Acid (Peroxynitrite)IBA 01/2020
1	3-nitrotyrosineIBA 01/2020
1	NADPH Oxidase 2IBA 01/2020
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2020
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2019
1	riociguatIBA 01/2019
1	Matrix Metalloproteinases (MMPs)IBA 01/2019
1	piclamilastIBA 01/2015
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2015
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2015
1	Tadalafil (Cialis)FDA Link 01/2015
1	actinomycin D1IBA 04/2014
1	Adenosylmethionine DecarboxylaseIBA 04/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2013
1	Biomarkers (Surrogate Marker)IBA 11/2013
1	AnionsIBA 11/2013
1	Pharmaceutical PreparationsIBA 11/2013
1	Environmental Pollutants (Pollutants, Environmental)IBA 11/2013

Therapy/Procedure

2	Therapeutics 01/2019 - 01/2015